The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| ACADIA PHARMACEUTICALS INC | Common | 004225108 | 104,247 | 1,950,000 | SH | SOLE | 1,950,000 | 0 | 0 | ||
| ACCELERON PHARMA INC | Common | 00434H108 | 198,307 | 1,550,000 | SH | SOLE | 1,550,000 | 0 | 0 | ||
| ADAPTIMMUNE THERAPEUTICS PLC | Sponsored ADR | 00653A107 | 19,135 | 3,550,000 | SH | SOLE | 3,550,000 | 0 | 0 | ||
| ADVERUM BIOTECHNOLOGIES INC | Common | 00773U108 | 86,720 | 8,000,000 | SH | SOLE | 8,000,000 | 0 | 0 | ||
| AMARIN CORP PLC | Sponsored ADR | 023111206 | 29,340 | 6,000,000 | SH | SOLE | 6,000,000 | 0 | 0 | ||
| AMICUS THERAPEUTICS INC | Common | 03152W109 | 207,810 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
| ARENA PHARMACEUTICALS INC | Common | 040047607 | 321,918 | 4,190,000 | SH | SOLE | 4,190,000 | 0 | 0 | ||
| ARGENX SE | Sponsored ADR | 04016X101 | 265,416 | 902,500 | SH | SOLE | 902,500 | 0 | 0 | ||
| ASCENDIS PHARMA | Sponsored ADR | 04351P101 | 300,204 | 1,800,000 | SH | SOLE | 1,800,000 | 0 | 0 | ||
| ATHENEX INC | Common | 04685N103 | 4,120 | 372,500 | SH | SOLE | 372,500 | 0 | 0 | ||
| AVADEL PHARMACEUTICALS PLC | Sponsored ADR | 05337M104 | 29,158 | 4,365,000 | SH | SOLE | 4,365,000 | 0 | 0 | ||
| AVIDITY BIOSCIENCES INC | Common | 05370A108 | 13,908 | 545,000 | SH | SOLE | 545,000 | 0 | 0 | ||
| BCTG ACQUISITION CORP | Common | 05492W103 | 9,152 | 800,000 | SH | SOLE | 800,000 | 0 | 0 | ||
| BIOMARIN PHARMACEUTICAL INC | Common | 09061G101 | 144,689 | 1,650,000 | SH | SOLE | 1,650,000 | 0 | 0 | ||
| BLACK DIAMOND THERAPEUTICS INC | Common | 09203E105 | 20,512 | 640,000 | SH | SOLE | 640,000 | 0 | 0 | ||
| CONSTELLATION PHARMACEUTICALS INC | Common | 210373106 | 84,960 | 2,950,000 | SH | SOLE | 2,950,000 | 0 | 0 | ||
| CUE BIOPHARMA INC | Common | 22978P106 | 5,661 | 452,500 | SH | SOLE | 452,500 | 0 | 0 | ||
| CYMABAY THERAPEUTICS INC | Common | 23257D103 | 59,122 | 10,300,000 | SH | SOLE | 10,300,000 | 0 | 0 | ||
| DECIPHERA PHARMACEUTICALS INC | Common | 24344T101 | 74,191 | 1,300,000 | SH | SOLE | 1,300,000 | 0 | 0 | ||
| FENNEC PHARMACEUTICALS INC | Common | 31447P100 | 12,442 | 1,670,000 | SH | SOLE | 1,670,000 | 0 | 0 | ||
| GENOCEA BIOSCIENCES INC | Common | 372427401 | 12,304 | 5,084,184 | SH | SOLE | 5,084,184 | 0 | 0 | ||
| HORIZON THERAPEUTICS PLC | Common | G46188101 | 658,350 | 9,000,000 | SH | SOLE | 9,000,000 | 0 | 0 | ||
| IOVANCE BIOTHERAPEUTICS INC | Common | 462260100 | 348,000 | 7,500,000 | SH | SOLE | 7,500,000 | 0 | 0 | ||
| ITEOS THERAPEUTICS INC | Common | 46565G104 | 15,557 | 460,000 | SH | SOLE | 460,000 | 0 | 0 | ||
| IVERIC BIO INC | Common | 46583P102 | 50,098 | 7,250,000 | SH | SOLE | 7,250,000 | 0 | 0 | ||
| KURA ONCOLOGY INC | Common | 50127T109 | 130,640 | 4,000,000 | SH | SOLE | 4,000,000 | 0 | 0 | ||
| MADRIGAL PHARMACEUTICALS INC | Common | 558868105 | 136,183 | 1,225,000 | SH | SOLE | 1,225,000 | 0 | 0 | ||
| MANNKIND CORP | Common | 56400P706 | 10,955 | 3,500,000 | SH | SOLE | 3,500,000 | 0 | 0 | ||
| MARINUS PHARMACEUTICALS INC | Common | 56854Q200 | 39,432 | 3,232,142 | SH | SOLE | 3,232,142 | 0 | 0 | ||
| MERSANA THERAPEUTICS INC | Common | 59045L106 | 180,948 | 6,800,000 | SH | SOLE | 6,800,000 | 0 | 0 | ||
| MIRATI THERAPEUTICS INC | Common | 60468T105 | 996,067 | 4,535,000 | SH | SOLE | 4,535,000 | 0 | 0 | ||
| NEKTAR THERAPEUTICS | Common | 640268108 | 26 | 100,000 | SH | Call | SOLE | 100,000 | 0 | 0 | |
| OLEMA PHARMACEUTICALS INC | Common | 68062P106 | 35,646 | 876,986 | SH | SOLE | 876,986 | 0 | 0 | ||
| PMV PHARMACEUTICALS INC | Common | 69353Y103 | 130,536 | 2,350,267 | SH | SOLE | 2,350,267 | 0 | 0 | ||
| PRAXIS PRECISION MEDICINES INC | Common | 74006W108 | 68,709 | 1,545,495 | SH | SOLE | 1,545,495 | 0 | 0 | ||
| RELAY THERAPEUTICS INC | Common | 75943R102 | 20,780 | 500,000 | SH | SOLE | 500,000 | 0 | 0 | ||
| RELMADA THERAPEUTICS INC | Common | 75955J402 | 48,907 | 1,525,000 | SH | SOLE | 1,525,000 | 0 | 0 | ||
| SAREPTA THERAPEUTICS INC | Common | 803607100 | 298,358 | 1,750,000 | SH | SOLE | 1,750,000 | 0 | 0 | ||
| SYNDAX PHARMACEUTICALS INC | Common | 87164F105 | 10,008 | 450,000 | SH | SOLE | 450,000 | 0 | 0 | ||
| THERAPEUTICS ACQUISITION CORP | Common | 88339T103 | 13,950 | 1,000,000 | SH | SOLE | 1,000,000 | 0 | 0 | ||
| TRAVERE THERAPEUTICS INC | Common | 89422G107 | 49,073 | 1,800,500 | SH | SOLE | 1,800,500 | 0 | 0 | ||
| TRILLIUM THERAPEUTICS INC | Common | 89620X506 | 85,318 | 5,800,000 | SH | SOLE | 5,800,000 | 0 | 0 | ||
| UNITED THERAPEUTICS CORP | Common | 91307C102 | 432,602 | 2,850,000 | SH | SOLE | 2,850,000 | 0 | 0 | ||
| XENON PHARMACEUTICALS INC | Common | 98420N105 | 43,064 | 2,800,000 | SH | SOLE | 2,800,000 | 0 | 0 | ||